Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
17/08/2026 22:36
BRIEF-Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights Aug 17 (Reuters) - Coherus Oncology Inc CHRS.O:
COHERUS ONCOLOGY ANNOUNCES SPECIAL DIVIDEND OF BIOSIMILAR CONTINGENT VALUE RIGHTS
COHERUS ONCOLOGY - TO BEGIN SALE PROCESS FOR LEGACY BIOSIMILAR ASSETS
Source text: ID:nGNX4VXbdX
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million